Thomas Moestrup

Thomas Moestrup is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Chief Executive Officer of Chr. Olesen Synthesis A/S since 2017, Thomas has a proven track record of leadership and strategic growth. Prior to this role, Thomas was the Chief Commercial Officer and General Manager for Europe at Cell Biotech International A/S, where a new growth strategy led to a significant revenue increase of 70-80%. Thomas's earlier experience includes serving as Director of Healthcare and Pharma at Persano Group, where responsibilities included general management and the development of commercial strategies. Additionally, Thomas was the Director of Operations at Propharma A/S, successfully managing contract manufacturing and optimizing the supply chain to cut product costs by 25-35%. Thomas holds an Executive MBA from Copenhagen Business School and an M.Sc in Pharmacy from the University of Copenhagen.